Annexon (ANNX) Other financing activities (2021 - 2026)
Annexon's (ANNX) quarterly Other financing activities came in at $936000.0 in Q1 2026, up 1409.68% year-on-year from $62000.0 in Q1 2025, and down 2.4% quarter-over-quarter from $959000.0 in Q4 2025.
Annexon (ANNX) Other financing activities (2021 - 2026) Analysis & Trends
Annexon's Other financing activities history runs 6 years deep, the most recent figure standing at $936000.0 for Q1 2026.
- On a quarterly basis, Other financing activities rose 1409.68% year-over-year to $936000.0 in Q1 2026; TTM through Mar 2026 was $2.5 million, a 561.27% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 31.41% from the prior year.
- Other financing activities eased to $936000.0 in Q1 2026 per ANNX's latest filing, from $959000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $959000.0 in Q4 2025 and bottomed at -$702000.0 in Q2 2024.
- The 5-year median for Other financing activities is $115500.0 (2023), against an average of $247312.5.
- Across the five-year window, Other financing activities slumped 2818.75% in 2023 and surged 1409.68% in 2026, its largest moves.
- Year by year, Other financing activities stood at $16000.0 in 2022, then slumped by 2818.75% to -$435000.0 in 2023, then soared by 172.18% to $314000.0 in 2024, then jumped by 205.41% to $959000.0 in 2025, then fell by 2.4% to $936000.0 in 2026.
- Per Business Quant, the three latest ANNX Other financing activities figures stand at $936000.0 (Q1 2026), $959000.0 (Q4 2025), and $478000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 936,000.00 |
| Mar 31, 2026 | 936,000.00 |
| Dec 31, 2025 | 959,000.00 |
| Dec 31, 2025 | 959,000.00 |
| Sep 30, 2025 | 478,000.00 |
| Sep 30, 2025 | 478,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Sep 30, 2024 | 703,000.00 |
| Sep 30, 2024 | 703,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Mar 31, 2024 | 917,000.00 |
| Mar 31, 2024 | 917,000.00 |
| Dec 31, 2023 | -435,000.00 |
| Dec 31, 2023 | -435,000.00 |